Stay updated on PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.

Latest updates to the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the former Revision: v3.6.0. This indicates a maintenance update to the page's build while leaving study content intact.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, and new user help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') were introduced, along with a formatting adjustment to the Intervention/Treatment heading and a site revision label (Revision: v3.6.0).SummaryDifference0.4%

- Check25 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a new version of the page's content and metadata.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new build of the page; the change affects only the version label and does not alter the study details or results.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s interface revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC: Pembrolizumab vs Chemo Clinical Trial page.